CAR T-cell therapy is a groundbreaking, one-time therapy that uses versions of your own immune cells to find and destroy tough-to-treat blood cancers, such as multiple myeloma and leukemia.
At BMC's CAR T-cell Therapy Program, we offer the same state-of-the-art CAR T-cell therapies as larger institutions, but with a more personalized approach that takes into account all of your medical needs and life circumstances. Together, our multidisciplinary team of experts is breaking down barriers to cancer treatment and providing all the care you need throughout your journey.
Our program is led by Fabio Petrocca, MD, a world-renowned expert in CAR T-cell therapies. Along with Petrocca, providers from specialties across the hospital have joined the CAR T-cell Therapy Program because they understand the importance of providing equitable access to this life-saving treatment for all patients who may benefit from it.
Frequently Asked Questions About CAR T-cell Therapy
A história de Arminta
Arminta Graham é rápida em dizer a todos: "A terapia CAR-T é a melhor coisa que já me aconteceu". Porém, quando lhe ofereceram o tratamento pela primeira vez, ela não tinha certeza se queria. Logo, ela mudou de ideia e se tornou a primeira paciente do BMC a receber essa terapia que salva vidas.
Condições que tratamos
Multiple Myeloma
Non-Hodgkin Lymphoma
Leukemia
Nossa equipe
The CAR T-cell Therapy Program at BMC brings together the expertise of a wide range of specialists. Led by Dr. Fabio Petrocca, a world-renowned expert in CAR T-cell therapy, our multidisciplinary team provides coordinated care between hematology, critical care, neurology, cardiology, blood bank, laboratory medicine, social work, pharmacy, and emergency medicine.